Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism.

Stuelten CH, Barbul A, Busch JI, Sutton E, Katz R, Sato M, Wakefield LM, Roberts AB, Niederhuber JE.

Cancer Res. 2008 Sep 15;68(18):7278-82. doi: 10.1158/0008-5472.CAN-08-1842.

2.

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

Hwang JY, Mangala LS, Fok JY, Lin YG, Merritt WM, Spannuth WA, Nick AM, Fiterman DJ, Vivas-Mejia PE, Deavers MT, Coleman RL, Lopez-Berestein G, Mehta K, Sood AK.

Cancer Res. 2008 Jul 15;68(14):5849-58. doi: 10.1158/0008-5472.CAN-07-6130.

3.

Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells.

Shojaei F, Ferrara N.

Cancer Res. 2008 Jul 15;68(14):5501-4. doi: 10.1158/0008-5472.CAN-08-0925. Review.

4.

Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.

Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK.

J Biol Chem. 2007 Oct 12;282(41):29919-26. Epub 2007 Aug 23.

5.

Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.

Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK.

Clin Cancer Res. 2007 Jun 1;13(11):3423-30.

6.

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A, Coleman RL, Gershenson DM, Schmandt R, Cole SW, Lopez-Berestein G, Sood AK.

Clin Cancer Res. 2006 Aug 15;12(16):4916-24.

7.

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK.

Nat Med. 2006 Aug;12(8):939-44. Epub 2006 Jul 23.

PMID:
16862152
8.

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK.

Cancer Res. 2005 Aug 1;65(15):6910-8.

9.
10.

Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.

Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M, Sood AK.

Clin Cancer Res. 2003 Oct 1;9(12):4514-21.

11.
12.

Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors.

Exton MS, Gierse C, Meier B, Mosen M, Xie Y, Frede S, Goebel MU, Limmroth V, Schedlowski M.

J Neuroimmunol. 2002 Oct;131(1-2):21-30.

PMID:
12458033
13.

The price of anticancer intervention. Does surgery promote metastasis?

Ben-Eliyahu S.

Lancet Oncol. 2002 Sep;3(9):578-9. Review. No abstract available.

PMID:
12233735
14.

The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats.

Gaspani L, Bianchi M, Limiroli E, Panerai AE, Sacerdote P.

J Neuroimmunol. 2002 Aug;129(1-2):18-24.

PMID:
12161016
15.

Increased rates of pulmonary metastases following sham laparotomy compared to CO2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine.

Wildbrett P, Oh A, Carter JJ, Schuster H, Bessler M, Jaboci CA, Whelan RL.

Surg Endosc. 2002 Aug;16(8):1162-9. Epub 2002 May 3.

PMID:
11984655
16.

Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflation.

Lee SW, Gleason N, Blanco I, Asi ZK, Whelan RL.

Surg Endosc. 2002 Jan;16(1):36-9. Epub 2001 Oct 19.

PMID:
11961601
17.
18.

Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications.

Sietses C, Beelen RH, Meijer S, Cuesta MA.

Langenbecks Arch Surg. 1999 Jun;384(3):250-8. Review.

PMID:
10437613
19.

The effect of surgical wounding on tumour development.

Hofer SO, Molema G, Hermens RA, Wanebo HJ, Reichner JS, Hoekstra HJ.

Eur J Surg Oncol. 1999 Jun;25(3):231-43. Review.

PMID:
10336800

Supplemental Content

Support Center